Immune Toxicity with Checkpoint Inhibition for Metastatic Melanoma: Case Series and Clinical Management

Immune checkpoint inhibitors (anti-PD-1 and anti-CTLA-4 antibodies) are a standard of care for advanced melanoma. Novel toxicities comprise immune-related adverse events (irAE). With increasing use, irAE require recognition, practical management strategies, and multidisciplinary care. We retrospecti...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Skin Cancer
Hlavní autoři: Lomax, Anna J., Lim, Jennifer, Cheng, Robert, Sweeting, Arianne, Lowe, Patricia, McGill, Neil, Shackel, Nicholas, Chua, Elizabeth L., McNeil, Catriona
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi 2018
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5828308/
https://ncbi.nlm.nih.gov/pubmed/29610684
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/9602540
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky